Oric Pharmaceuticals, Inc. financial data

Symbol
ORIC on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1425% % -0.73%
Debt-to-equity 7.1% % -24%
Return On Equity -39% % 13%
Return On Assets -36% % 11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100,358,242 shares 41%
Common Stock, Shares, Outstanding 98,528,949 shares 39%
Entity Public Float $862,400,000 USD 83%
Common Stock, Value, Issued $11,000 USD 57%
Weighted Average Number of Shares Outstanding, Basic 87,793,801 shares 26%
Weighted Average Number of Shares Outstanding, Diluted 87,793,801 shares 26%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $33,186,000 USD 15%
Operating Income (Loss) $143,004,000 USD -0.08%
Nonoperating Income (Expense) $13,536,000 USD -10%
Net Income (Loss) Attributable to Parent $129,468,000 USD -1.3%
Earnings Per Share, Basic -1.47 USD/shares 20%
Earnings Per Share, Diluted -1.47 USD/shares 20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $45,669,000 USD -23%
Assets, Current $288,466,000 USD 10%
Property, Plant and Equipment, Net $2,415,000 USD -17%
Operating Lease, Right-of-Use Asset $6,658,000 USD -21%
Other Assets, Noncurrent $7,247,000 USD -19%
Assets $408,890,000 USD 49%
Accounts Payable, Current $3,824,000 USD 147%
Accrued Liabilities, Current $16,593,000 USD -29%
Liabilities, Current $20,417,000 USD -18%
Operating Lease, Liability, Noncurrent $4,111,000 USD -33%
Other Liabilities, Noncurrent $4,111,000 USD -33%
Liabilities $24,528,000 USD -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $786,000 USD 107%
Retained Earnings (Accumulated Deficit) $692,242,000 USD -23%
Stockholders' Equity Attributable to Parent $384,362,000 USD 58%
Liabilities and Equity $408,890,000 USD 49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $32,533,000 USD -7.8%
Net Cash Provided by (Used in) Financing Activities $125,030,000 USD
Net Cash Provided by (Used in) Investing Activities $22,450,000 USD
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 98,528,949 shares 39%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,072,000 USD -131%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46,160,000 USD -23%
Deferred Tax Assets, Valuation Allowance $212,603,000 USD 23%
Deferred Tax Assets, Gross $214,715,000 USD 23%
Operating Lease, Liability $7,441,000 USD -20%
Depreciation $302,000 USD 16%
Payments to Acquire Property, Plant, and Equipment $387,000 USD 78%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $129,061,000 USD -1%
Lessee, Operating Lease, Liability, to be Paid $8,140,000 USD -23%
Property, Plant and Equipment, Gross $10,066,000 USD -3.2%
Operating Lease, Liability, Current $3,330,000 USD 4.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,503,000 USD 1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,455,000 USD 4.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.084 pure 1.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $699,000 USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,182,000 USD -57%
Deferred Tax Assets, Operating Loss Carryforwards $129,331,000 USD 43%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000,000 shares 0%
Unrecognized Tax Benefits $4,774,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,112,000 USD -18%
Share-based Payment Arrangement, Expense $25,037,000 USD 24%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%